BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 27192563)

  • 1. Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.
    Schildberg FA; Klein SR; Freeman GJ; Sharpe AH
    Immunity; 2016 May; 44(5):955-72. PubMed ID: 27192563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinhibitory Pathways in Immunotherapy for Cancer.
    Baumeister SH; Freeman GJ; Dranoff G; Sharpe AH
    Annu Rev Immunol; 2016 May; 34():539-73. PubMed ID: 26927206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.
    Janakiram M; Shah UA; Liu W; Zhao A; Schoenberg MP; Zang X
    Immunol Rev; 2017 Mar; 276(1):26-39. PubMed ID: 28258693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The B7:CD28 family and friends: Unraveling coinhibitory interactions.
    Burke KP; Chaudhri A; Freeman GJ; Sharpe AH
    Immunity; 2024 Feb; 57(2):223-244. PubMed ID: 38354702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD28-B7 Family of Co-signaling Molecules.
    Nagai S; Azuma M
    Adv Exp Med Biol; 2019; 1189():25-51. PubMed ID: 31758530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New checkpoints in cancer immunotherapy.
    Ni L; Dong C
    Immunol Rev; 2017 Mar; 276(1):52-65. PubMed ID: 28258699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantigen-Harboring Apoptotic Cells Hijack the Coinhibitory Pathway of T Cell Activation.
    Yakoub AM; Schulz R; Seiffert M; Sadek M
    Sci Rep; 2018 Jul; 8(1):10533. PubMed ID: 30002409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B7 family revisited.
    Greenwald RJ; Freeman GJ; Sharpe AH
    Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.
    Bour-Jordan H; Esensten JH; Martinez-Llordella M; Penaranda C; Stumpf M; Bluestone JA
    Immunol Rev; 2011 May; 241(1):180-205. PubMed ID: 21488898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.
    Picarda E; Ohaegbulam KC; Zang X
    Clin Cancer Res; 2016 Jul; 22(14):3425-3431. PubMed ID: 27208063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.
    Pentcheva-Hoang T; Corse E; Allison JP
    Immunol Rev; 2009 May; 229(1):67-87. PubMed ID: 19426215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B7-CD28 superfamily.
    Sharpe AH; Freeman GJ
    Nat Rev Immunol; 2002 Feb; 2(2):116-26. PubMed ID: 11910893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The B7/CD28 costimulatory family in autoimmunity.
    Keir ME; Sharpe AH
    Immunol Rev; 2005 Apr; 204():128-43. PubMed ID: 15790355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28 Costimulation: From Mechanism to Therapy.
    Esensten JH; Helou YA; Chopra G; Weiss A; Bluestone JA
    Immunity; 2016 May; 44(5):973-88. PubMed ID: 27192564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy.
    Khan M; Arooj S; Wang H
    Front Immunol; 2021; 12():651634. PubMed ID: 34531847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell costimulation and coinhibition: genetics and disease.
    Scandiuzzi L; Ghosh K; Zang X
    Discov Med; 2011 Aug; 12(63):119-28. PubMed ID: 21878189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.